These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16437248)

  • 1. [Intravesical therapy for overactive bladder].
    Pannek J; Grigoleit U; Wormland R; Goepel M
    Urologe A; 2006 Feb; 45(2):167-8, 170-3. PubMed ID: 16437248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravesical treatment of overactive bladder syndrome].
    Haferkamp A; Hohenfellner M
    Urologe A; 2006 Oct; 45(10):1283-8. PubMed ID: 16972089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravesical therapy for overactive bladder.
    Evans RJ
    Curr Urol Rep; 2005 Nov; 6(6):429-33. PubMed ID: 16238916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of intravesical oxybutynin in children with detrusor-sphincter dyssynergia: with special reference to age-dependent parameters.
    Humblet M; Verpoorten C; Christiaens MH; Hirche H; Jansen K; Buyse G; van Gool JD
    Neurourol Urodyn; 2015 Apr; 34(4):336-42. PubMed ID: 24436114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic effects and safety of modified intravesical oxybutynin chloride in patients with neurogenic detrusor overactivity: 3 years experience.
    Saito M; Watanabe T; Tabuchi F; Otsubo K; Satoh K; Miyagawa I
    Int J Urol; 2004 Aug; 11(8):592-6. PubMed ID: 15285747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The use of intravesical oxybutynin hydrochloride in patients with neurogenic bladder managed by intermittent catheterization].
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    Hinyokika Kiyo; 1995 Jul; 41(7):521-4. PubMed ID: 7668182
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effectiveness of intravesical oxybutynin, propantheline, and capsaicin in the management of neuropathic bladder following spinal cord injury.
    George J; Tharion G; Richar J; Macaden AS; Thomas R; Bhattacharji S
    ScientificWorldJournal; 2007 Oct; 7():1683-90. PubMed ID: 17982563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravesical neuromodulatory drugs: capsaicin and resiniferatoxin to treat the overactive bladder.
    Kim DY; Chancellor MB
    J Endourol; 2000 Feb; 14(1):97-103. PubMed ID: 10735579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravesical treatment of overactive bladder.
    Fowler CJ
    Urology; 2000 May; 55(5A Suppl):60-4; discussion 66. PubMed ID: 10767456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravesical oxybutynin chloride: experience with 42 patients.
    Weese DL; Roskamp DA; Leach GE; Zimmern PE
    Urology; 1993 Jun; 41(6):527-30. PubMed ID: 8516987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravesical instillation of oxybutynin hydrochloride for detrusor hyper-reflexia.
    O'Flynn KJ; Thomas DG
    Br J Urol; 1993 Nov; 72(5 Pt 1):566-70. PubMed ID: 10071538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravesical atropine compared to oral oxybutynin for neurogenic detrusor overactivity: a double-blind, randomized crossover trial.
    Fader M; Glickman S; Haggar V; Barton R; Brooks R; Malone-Lee J
    J Urol; 2007 Jan; 177(1):208-13; discussion 213. PubMed ID: 17162046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electromotive drug administration of lidocaine to anesthetize the bladder before intravesical capsaicin.
    Dasgupta P; Fowler CJ; Stephen RL
    J Urol; 1998 Jun; 159(6):1857-61. PubMed ID: 9598475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics, efficacy, and safety of intravesical formulation of oxybutynin in patients with detrusor overactivity.
    Lehtoranta K; Tainio H; Lukkari-Lax E; Hakonen T; Tammela TL
    Scand J Urol Nephrol; 2002 Feb; 36(1):18-24. PubMed ID: 12002352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urodynamic changes during therapeutic intravesical instillations of capsaicin.
    Chandiramani VA; Peterson T; Duthie GS; Fowler CJ
    Br J Urol; 1996 Jun; 77(6):792-7. PubMed ID: 8705210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor.
    Lose G; Nørgaard JP
    BJU Int; 2001 Jun; 87(9):767-73. PubMed ID: 11412211
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravesical oxybutynin: practicalities of clinical use.
    Guerrero K; Emery S; Owen L; Rowlands M
    J Obstet Gynaecol; 2006 Feb; 26(2):141-3. PubMed ID: 16483973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical vanilloids and neurogenic incontinence: ten years experience.
    Lazzeri M; Spinelli M; Zanollo A; Turini D
    Urol Int; 2004; 72(2):145-9. PubMed ID: 14963356
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravesical Electromotive Botulinum Toxin Type A (Dysport) Administration in Children With Myelomeningocele.
    Sharifi-Rad L; Ladi-Seyedian SS; Nabavizadeh B; Alijani M; Kajbafzadeh AM
    Urology; 2019 Oct; 132():210-211. PubMed ID: 31299327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Intravesical instillation of atropine in treatment of detrusor overactivity in children].
    Kroll P; Jankowski A; Martyński M
    Wiad Lek; 1998; 51 Suppl 3():87-91. PubMed ID: 9814113
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.